Skip to main content
Erschienen in: Infection 2/2016

15.08.2015 | Original Paper

Biomarker candidates for the detection of an infectious etiology of febrile neutropenia

verfasst von: Martin E. Richter, Sophie Neugebauer, Falco Engelmann, Stefan Hagel, Katrin Ludewig, Paul La Rosée, Herbert G. Sayer, Andreas Hochhaus, Marie von Lilienfeld-Toal, Tom Bretschneider, Christine Pausch, Christoph Engel, Frank M. Brunkhorst, Michael Kiehntopf

Erschienen in: Infection | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Infections and subsequent septicemia are major complications in neutropenic patients with hematological malignancies. Here, we identify biomarker candidates for the early detection of an infectious origin, and monitoring of febrile neutropenia (FN).

Methods

Proteome, metabolome, and conventional biomarkers from 20 patients with febrile neutropenia without proven infection (FNPI) were compared to 28 patients with proven infection, including 17 patients with bacteremia.

Results

Three peptides (mass to charge ratio 1017.4–1057.3; p-values 0.011–0.024), six proteins (mass to charge ratio 6881–17,215; p-values 0.002–0.004), and six phosphatidylcholines (p-values 0.007–0.037) were identified that differed in FNPI patients compared to patients with infection or bacteremia. Seven of these marker candidates discriminated FNPI from infection at fever onset with higher sensitivity and specificity (ROC-AUC 0.688–0.824) than conventional biomarkers i.e., procalcitonin, C–reactive protein, or interleukin–6 (ROC-AUC 0.535–0.672). In a post hoc analysis, monitoring the time course of four lysophosphatidylcholines, threonine, and tryptophan allowed for discrimination of patients with or without resolution of FN (ROC-AUC 0.648–0.919) with higher accuracy compared to conventional markers (ROC-AUC 0.514–0.871).

Conclusions

Twenty-one promising biomarker candidates for the early detection of an infectious origin or for monitoring the course of FN were found which might overcome known shortcomings of conventional markers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23(7):539–44.CrossRef von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis. 2004;23(7):539–44.CrossRef
2.
Zurück zum Zitat Toussaint E, Bahel-Ball E, Vekemans M, Georgala A, Al-Hakak L, Paesmans M, et al. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer. 2006;14(7):763–9.CrossRefPubMed Toussaint E, Bahel-Ball E, Vekemans M, Georgala A, Al-Hakak L, Paesmans M, et al. Causes of fever in cancer patients (prospective study over 477 episodes). Support Care Cancer. 2006;14(7):763–9.CrossRefPubMed
3.
Zurück zum Zitat Vidal L, Ben Dor I, Paul M, Eliakim-Raz N, Pokroy E, Soares-Weiser K, et al. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Syst Rev. 2013;10:CD003992.PubMed Vidal L, Ben Dor I, Paul M, Eliakim-Raz N, Pokroy E, Soares-Weiser K, et al. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Syst Rev. 2013;10:CD003992.PubMed
4.
Zurück zum Zitat Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18(16):3038–51.PubMed Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18(16):3038–51.PubMed
5.
Zurück zum Zitat Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection. 2008;36(5):396–407.CrossRefPubMed Sakr Y, Sponholz C, Tuche F, Brunkhorst F, Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection. 2008;36(5):396–407.CrossRefPubMed
6.
Zurück zum Zitat Prat C, Sancho JM, Dominguez J, Xicoy B, Gimenez M, Ferra C, et al. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma. 2008;49(9):1752–61.CrossRefPubMed Prat C, Sancho JM, Dominguez J, Xicoy B, Gimenez M, Ferra C, et al. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma. 2008;49(9):1752–61.CrossRefPubMed
7.
Zurück zum Zitat Abrahamsson J, Pahlman M, Mellander L. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy. Acta Paediatr. 1997;86(10):1059–64.CrossRefPubMed Abrahamsson J, Pahlman M, Mellander L. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy. Acta Paediatr. 1997;86(10):1059–64.CrossRefPubMed
8.
Zurück zum Zitat Buyukberber N, Buyukberber S, Sevinc A, Camci C. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients. Med Oncol. 2009;26(1):55–61.CrossRefPubMed Buyukberber N, Buyukberber S, Sevinc A, Camci C. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients. Med Oncol. 2009;26(1):55–61.CrossRefPubMed
9.
Zurück zum Zitat Uys A, Rapoport BL, Fickl H, Meyer PW, Anderson R. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10. Eur J Cancer Care (Engl). 2007;16(6):475–83.CrossRef Uys A, Rapoport BL, Fickl H, Meyer PW, Anderson R. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10. Eur J Cancer Care (Engl). 2007;16(6):475–83.CrossRef
10.
Zurück zum Zitat Fiusa MM, Costa-Lima C, de Souza GR, Vigorito AC, Aranha FJ, Lorand-Metze I, et al. A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia. Crit Care. 2013;17(4):R169.CrossRef Fiusa MM, Costa-Lima C, de Souza GR, Vigorito AC, Aranha FJ, Lorand-Metze I, et al. A high angiopoietin-2/angiopoietin-1 ratio is associated with a high risk of septic shock in patients with febrile neutropenia. Crit Care. 2013;17(4):R169.CrossRef
11.
Zurück zum Zitat Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis. 2004;4(12):751–60.CrossRefPubMed Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis. 2004;4(12):751–60.CrossRefPubMed
13.
Zurück zum Zitat Siqueira-Batista R, Mendonca EG, Gomes AP, Vitorino RR, Miyadahira R, Alvarez-Perez MC et al. Proteomic updates on sepsis. Rev Assoc Med Bras. 2012;58(3):376–82.PubMed Siqueira-Batista R, Mendonca EG, Gomes AP, Vitorino RR, Miyadahira R, Alvarez-Perez MC et al. Proteomic updates on sepsis. Rev Assoc Med Bras. 2012;58(3):376–82.PubMed
14.
Zurück zum Zitat Kiehntopf M, Nin N, Bauer M. Metabolism, metabolome, and metabolomics in intensive care: is it time to move beyond monitoring of glucose and lactate? Am J Respir Crit Care Med. 2013;187(9):906–7.CrossRefPubMed Kiehntopf M, Nin N, Bauer M. Metabolism, metabolome, and metabolomics in intensive care: is it time to move beyond monitoring of glucose and lactate? Am J Respir Crit Care Med. 2013;187(9):906–7.CrossRefPubMed
15.
Zurück zum Zitat Kiehntopf M, Schmerler D, Brunkhorst FM, Winkler R, Ludewig K, Osterloh D, et al. SELDI-based protein patterns in the diagnosis of SEPSIS/SIRS. Shock. 2011;36(6):560–9.CrossRefPubMed Kiehntopf M, Schmerler D, Brunkhorst FM, Winkler R, Ludewig K, Osterloh D, et al. SELDI-based protein patterns in the diagnosis of SEPSIS/SIRS. Shock. 2011;36(6):560–9.CrossRefPubMed
16.
Zurück zum Zitat Schmerler D, Neugebauer S, Ludewig K, Bremer-Streck S, Brunkhorst FM, Kiehntopf M. Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J Lipid Res. 2012;53(7):1369–75.CrossRefPubMedPubMedCentral Schmerler D, Neugebauer S, Ludewig K, Bremer-Streck S, Brunkhorst FM, Kiehntopf M. Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J Lipid Res. 2012;53(7):1369–75.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427–31.CrossRefPubMed Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):427–31.CrossRefPubMed
18.
Zurück zum Zitat Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2 k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci GMS e-J. 2010;8:Doc14. Reinhart K, Brunkhorst FM, Bone HG, Bardutzky J, Dempfle CE, Forst H. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2 k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci GMS e-J. 2010;8:Doc14.
19.
Zurück zum Zitat van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Specific investigation of sample handling effects on protease activities and absolute serum concentrations of various putative peptidome cancer biomarkers. Clin Proteom. 2010;6(4):115–27.CrossRef van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Specific investigation of sample handling effects on protease activities and absolute serum concentrations of various putative peptidome cancer biomarkers. Clin Proteom. 2010;6(4):115–27.CrossRef
20.
Zurück zum Zitat R_Core_Team. R. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2012. R_Core_Team. R. A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2012.
21.
Zurück zum Zitat Tukey JW. Exploratory data analysis. Reading, Mass. Boston: Addison-Wesley; 1977. Tukey JW. Exploratory data analysis. Reading, Mass. Boston: Addison-Wesley; 1977.
22.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
23.
Zurück zum Zitat Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839–43.CrossRefPubMed Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839–43.CrossRefPubMed
24.
Zurück zum Zitat Gupta A, Singh M, Singh H, Kumar L, Sharma A, Bakhshi S, et al. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol. 2010;27(4):1037–45.CrossRefPubMed Gupta A, Singh M, Singh H, Kumar L, Sharma A, Bakhshi S, et al. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol. 2010;27(4):1037–45.CrossRefPubMed
25.
Zurück zum Zitat Gaytan-Martinez J, Mateos-Garcia E, Sanchez-Cortes E, Gonzalez-Llaven J, Casanova-Cardiel LJ, Fuentes-Allen JL. Microbiological findings in febrile neutropenia. Arch Med Res. 2000;31(4):388–92.CrossRefPubMed Gaytan-Martinez J, Mateos-Garcia E, Sanchez-Cortes E, Gonzalez-Llaven J, Casanova-Cardiel LJ, Fuentes-Allen JL. Microbiological findings in febrile neutropenia. Arch Med Res. 2000;31(4):388–92.CrossRefPubMed
26.
Zurück zum Zitat Madani TA. Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection. 2000;28(6):367–73.CrossRefPubMed Madani TA. Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection. 2000;28(6):367–73.CrossRefPubMed
27.
Zurück zum Zitat Chan SM, Chadwick J, Young DL, Holmes E, Gotlib J. Intensive serial biomarker profiling for the prediction of neutropenic Fever in patients with hematologic malignancies undergoing chemotherapy: a pilot study. Hematology reports. 2014;6(2):5466.CrossRefPubMedPubMedCentral Chan SM, Chadwick J, Young DL, Holmes E, Gotlib J. Intensive serial biomarker profiling for the prediction of neutropenic Fever in patients with hematologic malignancies undergoing chemotherapy: a pilot study. Hematology reports. 2014;6(2):5466.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, et al. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med. 2000;28(7):2209–16.CrossRefPubMed Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, et al. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications. Crit Care Med. 2000;28(7):2209–16.CrossRefPubMed
29.
Zurück zum Zitat Aimoto M, Koh H, Katayama T, Okamura H, Yoshimura T, Koh S, et al. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia. Infection. 2014;42(6):971–9.CrossRefPubMed Aimoto M, Koh H, Katayama T, Okamura H, Yoshimura T, Koh S, et al. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia. Infection. 2014;42(6):971–9.CrossRefPubMed
30.
Zurück zum Zitat Beaufort N, Wojciechowski P, Sommerhoff CP, Szmyd G, Dubin G, Eick S, et al. The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochem J. 2008;410(1):157–65.CrossRefPubMed Beaufort N, Wojciechowski P, Sommerhoff CP, Szmyd G, Dubin G, Eick S, et al. The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin. Biochem J. 2008;410(1):157–65.CrossRefPubMed
31.
Zurück zum Zitat Dubin G. Extracellular proteases of Staphylococcus spp. Biol chem. 2002;383(7–8):1075–86.PubMed Dubin G. Extracellular proteases of Staphylococcus spp. Biol chem. 2002;383(7–8):1075–86.PubMed
32.
Zurück zum Zitat Ohbayashi T, Irie A, Murakami Y, Nowak M, Potempa J, Nishimura Y, et al. Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology. 2011;157(Pt 3):786–92.CrossRefPubMed Ohbayashi T, Irie A, Murakami Y, Nowak M, Potempa J, Nishimura Y, et al. Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology. 2011;157(Pt 3):786–92.CrossRefPubMed
33.
Zurück zum Zitat Simard M, Hill LA, Underhill CM, Keller BO, Villanueva I, Hancock RE, et al. Pseudomonas aeruginosa elastase disrupts the cortisol-binding activity of corticosteroid-binding globulin. Endocrinology. 2014;155(8):2900–8.CrossRefPubMedPubMedCentral Simard M, Hill LA, Underhill CM, Keller BO, Villanueva I, Hancock RE, et al. Pseudomonas aeruginosa elastase disrupts the cortisol-binding activity of corticosteroid-binding globulin. Endocrinology. 2014;155(8):2900–8.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Bergamini G, Di Silvestre D, Mauri P, Cigana C, Bragonzi A, De Palma A, et al. MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects. Integr Biol Quant Biosci Nano Macro. 2012;4(3):270–9. Bergamini G, Di Silvestre D, Mauri P, Cigana C, Bragonzi A, De Palma A, et al. MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects. Integr Biol Quant Biosci Nano Macro. 2012;4(3):270–9.
35.
Zurück zum Zitat Tilley D, Law R, Warren S, Samis JA, Kumar A. CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation. FEMS Microbiol Lett. 2014;356(1):53–61.CrossRefPubMed Tilley D, Law R, Warren S, Samis JA, Kumar A. CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation. FEMS Microbiol Lett. 2014;356(1):53–61.CrossRefPubMed
36.
Zurück zum Zitat Bras G, Bochenska O, Rapala-Kozik M, Guevara-Lora I, Faussner A, Kozik A. Extracellular aspartic protease SAP2 of Candida albicans yeast cleaves human kininogens and releases proinflammatory peptides, Met-Lys-bradykinin and des-Arg(9)-Met-Lys-bradykinin. Biol chem. 2012;393(8):829–39.CrossRefPubMed Bras G, Bochenska O, Rapala-Kozik M, Guevara-Lora I, Faussner A, Kozik A. Extracellular aspartic protease SAP2 of Candida albicans yeast cleaves human kininogens and releases proinflammatory peptides, Met-Lys-bradykinin and des-Arg(9)-Met-Lys-bradykinin. Biol chem. 2012;393(8):829–39.CrossRefPubMed
37.
Zurück zum Zitat Langley RJ, Tipper JL, Bruse S, Baron RM, Tsalik EL, Huntley J, et al. Integrative “omic” analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med. 2014;190(4):445–55.CrossRefPubMedPubMedCentral Langley RJ, Tipper JL, Bruse S, Baron RM, Tsalik EL, Huntley J, et al. Integrative “omic” analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med. 2014;190(4):445–55.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Langley RJ, Tsalik EL, van Velkinburgh JC, Glickman SW, Rice BJ, Wang C, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5(195):195ra95.PubMedPubMedCentral Langley RJ, Tsalik EL, van Velkinburgh JC, Glickman SW, Rice BJ, Wang C, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5(195):195ra95.PubMedPubMedCentral
39.
Zurück zum Zitat Ray S, Patel SK, Kumar V, Damahe J, Srivastava S. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures. Proteom Clin Appl. 2014;8(1–2):53–72.CrossRef Ray S, Patel SK, Kumar V, Damahe J, Srivastava S. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures. Proteom Clin Appl. 2014;8(1–2):53–72.CrossRef
40.
Zurück zum Zitat Memon RA, Holleran WM, Moser AH, Seki T, Uchida Y, Fuller J, et al. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol. 1998;18(8):1257–65.CrossRefPubMed Memon RA, Holleran WM, Moser AH, Seki T, Uchida Y, Fuller J, et al. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol. 1998;18(8):1257–65.CrossRefPubMed
41.
Zurück zum Zitat Lanza-Jacoby S, Wong SH, Tabares A, Baer D, Schneider T. Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochim Biophys Acta. 1992;1124(3):233–40.CrossRefPubMed Lanza-Jacoby S, Wong SH, Tabares A, Baer D, Schneider T. Disturbances in the composition of plasma lipoproteins during gram-negative sepsis in the rat. Biochim Biophys Acta. 1992;1124(3):233–40.CrossRefPubMed
42.
Zurück zum Zitat Drobnik W, Liebisch G, Audebert FX, Frohlich D, Gluck T, Vogel P, et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res. 2003;44(4):754–61.CrossRefPubMed Drobnik W, Liebisch G, Audebert FX, Frohlich D, Gluck T, Vogel P, et al. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res. 2003;44(4):754–61.CrossRefPubMed
43.
Zurück zum Zitat Read TE, Harris HW, Grunfeld C, Feingold KR, Kane JP, Rapp JH. The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J. 1993;14(Suppl K):125–9.PubMed Read TE, Harris HW, Grunfeld C, Feingold KR, Kane JP, Rapp JH. The protective effect of serum lipoproteins against bacterial lipopolysaccharide. Eur Heart J. 1993;14(Suppl K):125–9.PubMed
44.
Zurück zum Zitat Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest. 1990;86(3):696–702.CrossRefPubMedPubMedCentral Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest. 1990;86(3):696–702.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Tokumura A. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. Biochim Biophys Acta. 2002;1582(1–3):18–25.CrossRefPubMed Tokumura A. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. Biochim Biophys Acta. 2002;1582(1–3):18–25.CrossRefPubMed
46.
Zurück zum Zitat Le LQ, Kabarowski JHS, Weng ZG, Satterthwaite AB, Harvill ET, Jensen ER, et al. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity. 2001;14(5):561–71.CrossRefPubMed Le LQ, Kabarowski JHS, Weng ZG, Satterthwaite AB, Harvill ET, Jensen ER, et al. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity. 2001;14(5):561–71.CrossRefPubMed
47.
Zurück zum Zitat Kao CC, Bandi V, Guntupalli KK, Wu M, Castillo L, Jahoor F. Arginine, citrulline and nitric oxide metabolism in sepsis. Clin Sci (Lond). 2009;117(1):23–30.CrossRefPubMed Kao CC, Bandi V, Guntupalli KK, Wu M, Castillo L, Jahoor F. Arginine, citrulline and nitric oxide metabolism in sepsis. Clin Sci (Lond). 2009;117(1):23–30.CrossRefPubMed
48.
49.
Zurück zum Zitat Wijnands KA, Castermans TM, Hommen MP, Meesters DM, Poeze M. Arginine and citrulline and the immune response in sepsis. Nutrients. 2015;7(3):1426–63.CrossRefPubMedPubMedCentral Wijnands KA, Castermans TM, Hommen MP, Meesters DM, Poeze M. Arginine and citrulline and the immune response in sepsis. Nutrients. 2015;7(3):1426–63.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE. Sepsis: an arginine deficiency state? Crit Care Med. 2004;32(10):2135-45.CrossRefPubMed Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE. Sepsis: an arginine deficiency state? Crit Care Med. 2004;32(10):2135-45.CrossRefPubMed
51.
Zurück zum Zitat McGaha TL, Huang L, Lemos H, Metz R, Mautino M, Prendergast GC, et al. Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol Rev. 2012;249(1):135–57.CrossRefPubMedPubMedCentral McGaha TL, Huang L, Lemos H, Metz R, Mautino M, Prendergast GC, et al. Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol Rev. 2012;249(1):135–57.CrossRefPubMedPubMedCentral
Metadaten
Titel
Biomarker candidates for the detection of an infectious etiology of febrile neutropenia
verfasst von
Martin E. Richter
Sophie Neugebauer
Falco Engelmann
Stefan Hagel
Katrin Ludewig
Paul La Rosée
Herbert G. Sayer
Andreas Hochhaus
Marie von Lilienfeld-Toal
Tom Bretschneider
Christine Pausch
Christoph Engel
Frank M. Brunkhorst
Michael Kiehntopf
Publikationsdatum
15.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 2/2016
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0830-6

Weitere Artikel der Ausgabe 2/2016

Infection 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.